|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.7 CNY | -4.41% |
|
-7.14% | -30.97% |
Shanghai Rightongene Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 290.74 million compared to CNY 284.93 million a year ago. Net income was CNY 46.01 million compared to CNY 38.71 million a year ago.
Basic earnings per share from continuing operations was CNY 0.92 compared to CNY 0.93 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -30.97% | 200M | |
| -3.58% | 12.64B | |
| -1.48% | 8.46B | |
| +8.70% | 5.66B | |
| +25.61% | 5.27B | |
| -4.58% | 4.49B | |
| -51.80% | 3.11B | |
| +16.25% | 2.87B | |
| +30.25% | 2.31B | |
| -4.08% | 1.89B |
SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD. 